Why Have Over 3 Million People Around the World Chosen Phakic ICL?

To date, more than 3 million Phakic ICL lenses have been successfully implanted worldwide. This not only proves the outstanding effectiveness of the technology but also reflects the strong trust it has gained from both the medical community and real users.

So, what makes Phakic ICL so popular? Let’s explore why Phakic ICL is becoming a global trend in the treatment of refractive errors.

Advanced Technology from the United States

Phakic ICL is a product of STAAR Surgical—a leading American ophthalmic company with over 40 years of research and development in intraocular lens technology.

The Phakic ICL lens is made of Collamer®, a biocompatible material that does not trigger immune responses and is incredibly lightweight. Its central port design allows natural aqueous humor flow, minimizing the risk of increased intraocular pressure without the need for an additional peripheral iridotomy.

No Corneal Cutting – No Dry Eye

Unlike LASIK or SMILE, Phakic ICL does not involve altering the corneal tissue. This is especially important for:

• People with thin or irregular corneas
• Those who have had previous eye surgery
• Individuals with dry eyes, allergies, or light sensitivity

Because the corneal structure is left intact, Phakic ICL avoids corneal nerve damage—significantly reducing the risk of long-term dry eye symptoms after surgery.

Clear Vision Almost Immediately – Rapid Recovery

The Phakic ICL procedure takes only 20–30 minutes, with no pain, no stitches, and no bleeding. Most patients:

• Experience clear vision on the first day
• Go home the same day and recover within 1–2 days
• Can return to work and daily activities almost immediately

FDA-Approved and Trusted Globally

Phakic ICL is one of the few refractive treatments approved by the U.S. FDA, in addition to being endorsed by major medical authorities across Europe, Asia, and the Middle East.

Its widespread adoption in over 75 countries is a testament to its safety and long-term effectiveness.

Exceptionally High Satisfaction Rate – 99.4% Would Do It Again

According to STAAR Surgical’s research, 99.4% of patients surveyed said they would choose Phakic ICL again if needed. This is an outstanding figure in the world of refractive surgery, where patient comfort and trust are paramount.

Many celebrities, professional athletes, and ophthalmologists worldwide have chosen Phakic ICL to transform their vision.

Versatile Solution for Various Refractive Errors

Phakic ICL can treat:

• Myopia from -0.5 diopters to -20.0 diopters
• Astigmatism up to 6.0 diopters

It is considered an optimal solution for individuals who are not eligible for LASIK or SMILE.

Real People, Real Results

From the U.S., Japan, and Europe to Vietnam, more and more patients are sharing their experiences of seeing clearly—as if they were never nearsighted—just hours after undergoing Phakic ICL. They return to work, daily life, travel, and sports with a new perspective—sharp, vivid vision without the need for glasses.

Why You Should Consider Phakic ICL Today

• Globally proven technology
• Trusted by over 3 million users
• Non-invasive to corneal tissue
• Fast, long-lasting visual results
• A perfect solution if you’ve been denied LASIK

Phakic ICL is more than just a lens—it’s a life-changing upgrade to your quality of life. If you’re looking for a safe, effective, and proven vision correction solution, now is the time to act.